Filing Flows

Filing Flows › Intelligent Bio Solutions (INBS) › Q2 FY25

Intelligent Bio Solutions (INBS) Q2 FY25 earnings results (second quarter fiscal 2025)

10-Q filed Feb 13, 2025

Intelligent Bio Solutions (INBS) reported revenue of $741K for the second quarter fiscal 2025 (Q2 FY25), -19% from a year earlier and -26% from the quarter before. Operating margin was -305.5%, net loss $2.3M (304.5% of revenue).

Revenue$741K
Year over year-19%
Quarter over quarter-26%
Operating margin-305.5%
Net earnings−$2.3M

Intelligent Bio Solutions, Q2 FY25: revenue $741K (-19% year over year), operating margin -305.5%, net loss $2.3M, operating cash flow −$2.3M. The chart follows the revenue to costs, profit and cash.

Q2 FY25AmountQ/QY/Y
Revenue$741K-26%-19%
Operating profit−$2.3M——
Net earnings−$2.3M——
Operating cash flow−$2.3M——

What changed

Revenue was $741K in Q2 FY25, down 19% year over year and down 26% from the previous quarter. Intelligent Fingerprinting Products was the largest line at 87% of revenue. Intelligent Fingerprinting Products lost $178K year over year (down 22%), 101% of the total change.

Gross margin was 30.1%, up 8.4 points from a year earlier. Operating costs exceeded revenue by $2.3M, an operating margin of -305.5%. Operating expenses grew 14% against a revenue fall of 19%. The fastest-growing cost line was Other operating costs (+40%). The quarter ended with a net loss of $2.3M, narrower than the previous quarter's $2.7M loss. Minority interests bore $7K of it: to shareholders the quarter was a loss of $2.2M.

Operating cash flow was −$2.3M. Non-cash charges added back $247K of depreciation and amortization and $12K of share-based compensation. Working capital and other items used $327K.

Questions

What was Intelligent Bio Solutions' revenue in the second quarter fiscal 2025?

Intelligent Bio Solutions (INBS) reported revenue of $741K for the second quarter fiscal 2025 (Q2 FY25), -19% from a year earlier and -26% from the quarter before.

Was Intelligent Bio Solutions profitable in the second quarter fiscal 2025?

Operating loss was $2.3M (-305.5% of revenue) and net loss $2.3M.

Open the interactive Sankey →

Source: Intelligent Bio Solutions 10-Q on SEC EDGAR.